The outcomes of marginal donor hearts compared with ideal donors: a single-center experience in Iran
- PMID: 35919203
- PMCID: PMC9296973
- DOI: 10.4285/kjt.22.0004
The outcomes of marginal donor hearts compared with ideal donors: a single-center experience in Iran
Abstract
Background: Heart transplantation has been considered the gold-standard treatment for patients with end-stage heart failure. This study assessed the survival outcomes of marginal donor hearts compared with ideal donor hearts in Iran.
Methods: This retrospective study is based on the follow-up data of heart donors and recipients in the Sina Hospital Organ Procurement Unit. Among the 93 participants, 75 were categorized as ideal donors (group A) and 18 as marginal donors (group B). Group C included heart recipients who received a standard organ, and group D included heart recipients who received a marginal one. To analyze differences in patient characteristics among the groups, posttransplant heart survival was assessed in all groups. All data were obtained from the hospital records.
Results: The mean age of the donors was 26.27±11.44 years (median age, 28 years). The marginal age showed a significant association with donor age. The age of recipients had a significant effect on survival days in the ideal group. Most patients survived for at least 1 year, with a median of 645 days in recipients from marginal donors and 689 days in recipients from ideal donors.
Conclusions: Considering the lack of organ availability in Iran, it may be possible to use marginal donors for marginal recipients, therefore reducing the number of people on the waitlist. We also recommend establishing a national marginal donor system specifically for Iranian patients to extend the donor pool.
Keywords: Graft survival; Heart transplantation; Organ donation; Organ transplantation.
Copyright © 2022 The Korean Society for Transplantation.
Figures
Similar articles
-
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up.J Clin Med. 2023 May 16;12(10):3505. doi: 10.3390/jcm12103505. J Clin Med. 2023. PMID: 37240611 Free PMC article.
-
Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation.J Heart Lung Transplant. 2000 Dec;19(12):1199-204. doi: 10.1016/s1053-2498(00)00215-1. J Heart Lung Transplant. 2000. PMID: 11124490
-
The Effect of Ideal/Standard Donor and Marginal Donor Use on Primary Graft Dysfunction After Lung Transplantation in Turkey.Eurasian J Med. 2023 Feb;55(1):69-73. doi: 10.5152/eurasianjmed.2023.23007. Eurasian J Med. 2023. PMID: 36861870 Free PMC article.
-
Expanding the donor pool: use of marginal donors for solid organ transplantation.Clin Transplant. 1996 Feb;10(1 Pt 1):1-19. Clin Transplant. 1996. PMID: 8652891 Review.
-
Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience.Transpl Int. 2008 Feb;21(2):113-25. doi: 10.1111/j.1432-2277.2007.00603.x. Epub 2007 Dec 5. Transpl Int. 2008. PMID: 18062790 Review.
Cited by
-
Is there any relationship between red blood cell distribution width and prognosis of brain death?Caspian J Intern Med. 2023 Winter;14(1):37-42. doi: 10.22088/cjim.14.1.37. Caspian J Intern Med. 2023. PMID: 36741490 Free PMC article.
References
-
- Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:996–1008. doi: 10.1016/j.healun.2014.08.003. - DOI - PubMed
LinkOut - more resources
Full Text Sources